Skip to main content

UBS Group AG

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1610520 ZURICH, V8

Position in ADPT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,136,684
-$5,177,008 QoQ
Shares Held
225,986
-55.9% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.12251201401857.ToString("F0")% Shared 0.ToString("F0")% None 0.8774879859814325.ToString("F0")%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,686,646,466 across 46 Diagnostics & Research names. ADPT ranks #28 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADPT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,136,684 225,986
2025-12-31 $8,313,692 511,927
2025-09-30 $3,799,539 253,980
2025-06-30 $5,305,479 455,406
2025-03-31 $2,047,833 275,617
2024-12-31 $2,381,561 397,258
2024-09-30 $374,532 73,151
2024-06-30 $205,004 56,631
2024-03-31 $461,003 143,615
2023-12-31 $649,347 132,520
2023-09-30 $492,231 90,318
2023-06-30 $686,707 102,341
2023-03-31 $766,954 86,858
2022-12-31 $474,717 62,136
2022-09-30 $192,275 27,005
2022-06-30 $204,515 25,280
2022-03-31 $689,168 49,652
2021-12-31 $1,391,831 49,602
2021-09-30 $1,769,450 52,058
2021-06-30 $625,034 15,297
2021-03-31 $884,954 21,981
2020-12-31 $1,358,037 22,967
2020-09-30 $1,297,350 26,678
2020-06-30 $1,113,319 23,012
2020-03-31 $742,226 26,718